Trial Profile
A Phase 1, Open Label, Non-randomized, Two-cohort, Single-sequence, Crossover Study to Investigate the Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin/telmisartan (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Yuhan
- 17 Feb 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 25 Sep 2014 New trial record